Revised FY26 results submitted with qualified auditor opinion

Qualified OpinionEmphasis Of MatterGoing ConcernResults View source PDF Explain this filing

TAKE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.5%Reaction day

₹30.00

prior close

₹30.00

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-0.7%-0.8% vs market

Healthcare Research Analytics & Technology peers, median of 5sector-1.1%-0.4% vs sector

On the reaction day the stock moved 0.8 pts less than Nifty Microcap 250 and 0.4 pts less than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-2.1

15m

-1.7

30m

-1.7

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.5-0.7-0.8-1.1-0.4

Next day

-2.3-0.8-1.5-1.0-1.4

-7.5-1.4-6.1+0.0-7.5

-11.3-1.7-9.6-1.5-9.7

-15.7-0.7-15.0+3.0-18.7

-19.9-0.5-19.4+2.3-22.2

-20.1+0.0-20.1+3.1-23.2

15d

-30.8+0.5-31.3+0.9-31.7

-31.0-1.9-29.1-0.3-30.7

-34.0+4.3-38.3+8.8-42.8

-47.0+5.8-52.8+10.3-57.3

UpDownMarket · Nifty Microcap 250Sector · Healthcare Research Analytics & Technology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Take Solutions resubmitted FY26 audited results with no change in numbers, only format compliance. Standalone net profit Rs 271.91 lakhs versus a loss of Rs 6,973.56 lakhs last year. Consolidated profit Rs 1,084.91 lakhs. Auditor issued qualified opinion on disputed income tax assets of about Rs 875.80 lakhs (standalone) and Rs 1,247.60 lakhs (consolidated), repetitive qualification since FY23. Going concern emphasis of matter noted. Debt cleared using Ecron Acunova divestment proceeds.

Likely market impact

Turnaround from loss to profit is positive, but qualified audit opinion on disputed tax assets and repetitive qualification since FY23 remains a concern for shareholders.